- Weather | Horoscope | Stocks
expressindia web
HomeBlogsCricketAstrologyShoppingTendersClassifieds OpinionsTravel
| Make this your homepage | Archive
Expressindia » Story

Kargil won, armyman losing son’s battle

Font Size -

PALLAVI SINGH

Posted online: Sunday , May 04, 2008 at 12:27:10
Updated: Sunday , May 04, 2008 at 12:27:10


New Delhi, May 3 Doctors say stem cell treatment for Naik Subedar’s son ‘not recommended’

With nine Army medals to his credit and a service record that lists the Kargil War and Operation Parakram, Naik Subedar Rajesh Lal Verma can’t get himself to win the mundane battles of life. Or, so it seems.

Bedridden for the last 19 months, after a road accident inflicted severe head injuries, his 19-year-old son Amit Verma today survives on a liquid diet, cannot speak; and sometimes, as if to mark a rare departure from his crippled state, manages to hold his hands up and break into a smile.

In spite of desperate visits to half a dozen hospitals and intermittent hospitalisation, he has remained bedridden since October 6, 2006, when his motorcycle skidded off the road while returning from college in Secunderabad.

And all this because the four Army hospitals across the country that have treated him and the two in Delhi — the All India Institute of Medical Sciences and Sir Ganga Ram Hospital (SGRH) — that turned him away expressing helplessness, do not deal in stem cell therapy for his Diffuse Axonal injury, the result of a severe whiplash injury that renders a patient comatose or, as in Amit’s case, in a vegetative state. From the Military Hospital in Secunderabad to Command Hospital (Southern Command) in Pune, from where Verma was referred to the Army Hospital (Research and Referral) in Delhi between October 2006 and February 2007, none deal with stem cell therapy — the only ray of hope for the Vermas — that is widely considered potent enough for the development of therapies for untreatable diseases.

“We do offer stem cell treatment for neurological disorders like stroke, Parkinson’s Disease, heart ailments, cancer and spinal injury. Head injuries are quite vast in number and therapies for various complications are still in the research stage,” says Dr Y K Gupta, public relations officer at AIIMS.

Dr Ish Anand, neurosurgeon at SGRH, who saw Amit’s case, says stem cell therapy is “still in its primitive stages”. “Stem cell is not recommended. At SGRH, this treatment is still in its primitive stage. Till now, there have been no authentic reports on whether this therapy brings about any improvement in patients’ status. My experience says that stem cell cases show no improvement,” Anand says.

As in the West, doctors here too are debating the ethical aspect of the therapy. While scientists say stem cells may be used to replace or repair damaged cells and have the potential to drastically change the treatment of conditions like cancer, Alzheimer’s, Parkinson’s Disease and even paralysis, divisions over how to conduct that research run deep.

And, irrespective of the raging debate, Nu Tech Mediworld (NTM), a multi-speciality hospital in Green Park, has offered help to the Vermas. But at a price: Rs 8-10 lakh for three stages of cure.

“I’ve diagnosed Amit’s case and recommend stem cell therapy. But since the treatment is very new, there is no guarantee of full recovery. We’ll try the regeneration of his brain since it’s completely damaged,” says Dr Geeta Shroff, who examined Amit’s case at Nu Tech Mediworld.

But, in a letter dated March 16, 2008, the Army has turned down a request for funding Amit’s treatment at NTM, saying that “Nu Tech Mediworld is not an empanelled hospital and it may not be feasible for military hospitals to refer the case for treatment under the government expense/reimbursement basis”. The Ministry of Defence didn’t respond to an e-mail query sent by The Indian Express on the issue.

And, after taking a loan to meet treatment expenses of more than Rs 3 lakh in the past 19 months — in addition to the subsidised treatment at Army hospitals — Verma has made several requests for help before everyone within his reach: the Army, local politicians in his home town of Raebareilly in Uttar Pradesh and even scientists at Johns Hopkins University in the US.

And while he goes from door to door for help with unstinted hope, his younger son has discontinued his studies and his wife has sold all her jewellery.

Stem cell
* Stem cells are undifferentiated cells that go on to develop into any of the more than 200 types of cells the adult human body is constituted of.
* Most research has been conducted on embryonic stem cell lines — cultures of cells derived from four or five-day-old embryos or fertilised cells. Opponents of embryonic stem cell research, which often uses embryos discarded by fertility clinics, want it to be severely restricted or banned outright as ‘inhumane’.
* Stem cell research in India made it to the headlines when the US Department of Health disclosed its interest in funding stem cell research in two Indian centres — Reliance Life Sciences (RLS) and the National Centre for Biological Sciences (NCBS). RLS, backed by industry major Reliance Ltd, ranks third among the top-10 institutes worldwide working on stem cells. Dr Firuza Parikh, the creator of the first Intra Cytoplasmic Sperm Injection (ICSI) child in India, heads the centre. NCBS has been working on stem cells since 1999 and has three documented stem cell lines.
* Stem cell facilities have also been established in hospitals like the Post Graduate Institute of Medical Education & Research (PGIMER) in Chandigarh; Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) in Lucknow; LV Prasad Eye Institute (LVPEI) in Hyderabad and KEM Hospital in Mumbai, apart from Maulana Azad Medical College in Delhi. LVPEI grabbed headlines recently when its doctors succeeded in transplanting a stem cell-derived cornea, a treatment available only in the US at the time.

Bookmark this Page
  • Digg

    On Digg, users share intersting online content by submitting links to the site. At that point, the Digg audience can vote on whether or not they think it is interesting. Articles with lots of votes, or "diggs," rise up higher on the site's main page and topical subsection pages. Another form of social sharing, this site also lets users categorize the content they are submitting to Digg and label it with descriptions of up to 350 characters. Digg users can also submit comments on each content item submitted to the site.

    To register, go to: http://digg.com/register

    del.icio.us

    At its most basic level, del.icio.us allows users to save their bookmarks online. Del.icio.us also gives users the ability to "tag" their bookmarks with descriptive category names. For example, someone who has bookmarked multiple Web pages that deal with the Washington Nationals baseball team could tag those links with any terms they want, like "baseball," "nationals," "natsfan," etc.

    As members of a "social bookmarking" community, del.icio.us sers can also see how many other people have bookmarked the same pages, and they can look at those users' bookmark collections to find other interesting online content.

    To register, go to: http://del.icio.us/register

    Reddit

    Reddit allows users to submit news articles and other online content to the site. Users also give articles a thumbs-up or thumbs-down. Reddit then uses those votes to build a user profile and to find articles to recommend to you. Users can also submit comments on items posted to the site.

    To register, go to: http://reddit.com/login

Rate this Article
1
Rating
Ads by Google
Post Comments
Name* Email ID*
Subject* Country*
Message*
Characters remaining
 
TERMS OF USE: The views represented here are not neccesarily endorsed by www.expressindia.com and its allied websites. All messages will be moderated and no message that has inflammatory, abusive, derogatory language or any language deemed unfit for publication by the editor will be displayed. Though it will be endeavoured that as many messages as possible be displayed, there will be time lag between the submission and publication of the messages. The website reserves the right to publish or reject any message.
I agree to the terms of use.
UNPA divide: ‘Kingmaker’ Naidu faces biggest...‘Shock would have been lesser had Ravi died ...Little surprise: How Left always played the ...Sena to Cong: Go for fresh polls, not number...Arushi murder: 38 days on, CBI adds one more...Deny visa to Modi again, US panel tells Govt

© 2008 Indian Express Newspapers (Mumbai) Ltd. All rights reserved
The Indian Express Group | Advertise With Us | Privacy Policy | Feedback | Work With Us | Site Map